Trial reportBMC psychiatry2026
Investigating the effect of eye movement desensitization and reprocessing on internalized stigma in patients with major depressive disorder: a randomized controlled trial.
Trial report in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor Depressive Disorder (MDD) is one of the most prevalent mood disorders, and internalized stigma remains a significant challenge faced by individuals. Novel therapeutic approaches, such as Eye Movement Desensitization and Reprocessing (EMDR), may help address this issue. This study aimed to investigate the effect of EMDR on internalized stigma in patients with MDD.
methodsThis study was a Randomized Controlled Trial (RCT) that included 66 patients with MDD at Shahid Rajaei Hospital in Yasuj, Iran, in 2025. Patients were selected using convenience sampling and randomly allocated to either the intervention group (n = 33; receiving seven individual EMDR sessions, each lasting 45-90 min) or the control group (n = 33; receiving standard treatment). Internalized stigma was assessed using the Internalized Stigma of Mental Illness (ISMI) scale at baseline, post-intervention, and three-month follow-up. Data were analyzed using descriptive statistics, paired and independent t-tests, repeated-measures analysis of variance, and analysis of covariance (ANCOVA) in SPSS version 27.
resultsThe adjusted mean total internalized stigma score in the intervention group was significantly lower than in the control group at post-test (61.37 vs. 93.78) and three-month follow-up (54.02 vs. 97.16) (P < 0.01). A significant improvement was also observed across all subscales (Alienation, Stereotype Endorsement, Perceived Discrimination, Social Withdrawal, and Stigma Resistance) in favor of the intervention group at both time points (P < 0.001).
conclusionsEMDR is an effective and non-invasive intervention that helps reduce internalized stigma in patients with MDD.
trial registrationIranian Registry of Clinical Trials (IRCT): IRCT20250111064354N1. Registered 9 March 2025, retrospectively registered.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.